|
CNKSR3 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.6278089987054E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.01849672929211E-11 |
| Normal-vs-Stage2 |
1.47589718224594E-11 |
| Normal-vs-Stage3 |
4.77395900588817E-15 |
| Normal-vs-Stage4 |
3.01479996522858E-09 |
| Stage1-vs-Stage2 |
1.771210E-01 |
| Stage1-vs-Stage3 |
7.131700E-02 |
| Stage1-vs-Stage4 |
6.140200E-01 |
| Stage2-vs-Stage3 |
8.554600E-01 |
| Stage2-vs-Stage4 |
6.071800E-01 |
| Stage3-vs-Stage4 |
4.554600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.57305288187126E-12 |
| Normal-vs-AfricanAmerican |
2.019700E-04 |
| Normal-vs-Asian |
2.78419953758657E-10 |
| Caucasian-vs-AfricanAmerican |
5.962800E-01 |
| Caucasian-vs-Asian |
3.455200E-01 |
| AfricanAmerican-vs-Asian |
2.812200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.32627242521721E-12 |
| Normal-vs-Female |
1.66466840312296E-12 |
| Male-vs-Female |
7.428200E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.00310048734809E-10 |
| Normal-vs-Age(41-60Yrs) |
<1E-12 |
| Normal-vs-Age(61-80Yrs) |
1.71229697087938E-12 |
| Normal-vs-Age(81-100Yrs) |
5.640300E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.344770E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.824400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.464400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.874400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.985800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.877800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
6.589700E-02 |
| Classical-VS-Follicular |
9.343800E-02 |
| Classical-VS-Other |
4.830800E-01 |
| Classical-VS-Normal |
1.20899956712606E-11 |
| Tall-VS-Follicular |
4.939000E-01 |
| Tall-VS-Other |
9.348600E-01 |
| Tall-VS-Normal |
8.3356999081019E-10 |
| Follicular-VS-Other |
7.632200E-01 |
| Follicular-VS-Normal |
1.65145674912992E-12 |
| Other-VS-Normal |
3.398800E-04 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.55031584528842E-15 |
| Normal-vs-N1 |
6.66070000265861E-08 |
| N0-vs-N1 |
7.844200E-01 |
|
|
